secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001641172-25-013937
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics announces 1-for-6 reverse stock split effective June 10, 2025
----------------------------------------------------------------------------

- Reverse stock split ratio of 1-for-6, effective 12:01 a.m. ET on June 10, 2025.
- Common stock to trade on Nasdaq under symbol BBLG starting June 10; warrants unchanged (BBLGW).
- New CUSIP for common stock is 098070600; par value remains $0.001 per share.
- Fractional shares rounded up to nearest whole share; authorized shares unchanged.
- Proportionate adjustments to exercise prices and shares issuable under warrants and equity awards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225013937/0001641172-25-013937-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000164117225013937/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-013937

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer